Key facts
- This page summarizes Erica J. Rogers's Form 4 filing for Silk Road Medical Inc.
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Jul 2023, 18:34.
Erica J. Rogers - 11 Jul 2023 Form 4 Insider Report for Silk Road Medical Inc
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 11 Jul 2023
- Net transaction value
- -$29,960
- SEC form
- 4
- Accepted by SEC
- 13 Jul 2023, 18:34:48 UTC
- Prior SEC filing
- 12 Jun 2023
- Next SEC filing
- 10 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Mhairi Jones, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Erica J. Rogers filed Form 4 for Silk Road Medical Inc on 13 Jul 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: -$29,960.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SILK
transaction
Common Stock
Options Exercise
- Transaction value
- $1,600
- Shares
- +1,000
- Change %
- +0.37%
- Price
- $1.60*
- Shares after
- 270,639
- Date
- 11 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
SILK
transaction
Common Stock
Sale
- Transaction value
- $31,560
- Shares
- -1,000
- Change %
- -0.37%
- Price
- $31.56
- Shares after
- 269,639
- Date
- 11 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
SILK
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 83,843
- Date
- 11 Jul 2023
- Ownership
- Trustees of The Surace/Rogers Family Trust
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SILK
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -6.8%
- Price
- $0.000000
- Shares after
- 13,654
- Date
- 11 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,000
- Exercise price
- $1.60
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 8, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Footnote F2
These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
Footnote F3
All of the shares subject to the option are fully vested and exercisable as of the date hereof.